insights_auto
Outlook: 61.5% bullish·15.4% bearish
Go to analysischevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
92,21 $
arrow_downward
-1,05%(-0,98) 1D
5 հոկ, 13:24:24 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
93,02 $
High
95,01 $
Low
89,49 $
Mkt. cap
8,13 մլրդ
Avg. vol.
1,32 մլն
Volume
219,89 հզր
52-wk high
110,18 $
52-wk low
15,90 $
EPS
-2,32 $
Beta
3,10
Shares outstanding
88,17 մլն
No. of employees
125
Open
93,02 $
High
95,01 $
Low
89,49 $
Mkt. cap
8,13 մլրդ
Avg. vol.
1,32 մլն
Volume
219,89 հզր
52-wk high
110,18 $
52-wk low
15,90 $
EPS
-2,32 $
Beta
3,10
Shares outstanding
88,17 մլն
No. of employees
125
News stories
From web sources and news partners
sUAS News
·
24 րոպե առաջ
Powerus (Nasdaq: PUSA) Awarded $82 Million Order for Counter-Unmanned Aerial Systems
WFMJ
·
27 րոպե առաջ
US stocks are rising near their records, with the Nasdaq composite on track for an all-time high
www.marketscreener.com
·
20 րոպե առաջ
SCWorx Corp. Announces Nasdaq Hearings Panel Grants Request for Reconsideration and Approves Continued Listing on The Nasdaq Capital Market
Seeking Alpha
·
1 ժամ առաջ
S&P 500 nears record high despite the struggling underlining breadth
About Spyre Therapeutics Inc
CEO-
Employees125
Founded01 հնվ, 2013 թ.
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitespyre.com